These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 23263559)

  • 21. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
    Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.
    Perrakis A; Schwarz K; Yedibela S; Croner RS; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3702-7. PubMed ID: 22172830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis.
    Abecassis MM; Seifeldin R; Riordan ME
    Transplant Proc; 2008 Jun; 40(5):1443-5. PubMed ID: 18589126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study.
    Oh CK; Bang JB; Kim SJ; Huh KH; Kim SJ; Jeon JS; Han SY; Cho HR; Kwon YJ; Lee SH; Kim YS
    Asian J Surg; 2020 Jun; 43(6):660-667. PubMed ID: 31353239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The once-daily formulation of tacrolimus: a step forward in kidney transplantation?
    Hougardy JM; de Jonge H; Kuypers D; Abramowicz D
    Transplantation; 2012 Feb; 93(3):241-3. PubMed ID: 22234346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications.
    Veroux M; Grosso G; Ekser B; Corona D; Giaquinta A; Veroux P
    Transplantation; 2012 May; 93(9):895-9. PubMed ID: 22298033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
    Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
    Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen.
    Han DJ; Park JB; Kim YS; Kim SJ; Ha J; Kim HC; Kim SJ; Moon IS; Yang CW
    Transplant Proc; 2012 Jan; 44(1):115-7. PubMed ID: 22310592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-month experience with tacrolimus once-daily regimen in stable renal allografts.
    Diez Ojea B; Alonso Alvarez M; Aguado Fernández S; Baños Gallardo M; García Melendreras S; Gómez Huertas E
    Transplant Proc; 2009; 41(6):2323-5. PubMed ID: 19715908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation.
    Iaria G; Sforza D; Angelico R; Toti L; de Luca L; Manuelli M; Bellini I; Manzia TM; Anselmo A; Tisone G
    Transplant Proc; 2011 May; 43(4):1028-9. PubMed ID: 21620043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study.
    Doesch AO; Mueller S; Konstandin M; Celik S; Erbel C; Kristen A; Frankenstein L; Koch A; Dengler TJ; Ehlermann P; Zugck C; De Geest S; Katus HA
    Transplant Proc; 2010 Dec; 42(10):4238-42. PubMed ID: 21168673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
    Tsuchiya T; Ishida H; Tanabe T; Shimizu T; Honda K; Omoto K; Tanabe K
    Transplantation; 2013 Jul; 96(2):198-204. PubMed ID: 23792649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH; Lee SD; Kim YK; Park SJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR
    Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
    Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
    Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
    Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
    Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J; Guillaud O; Boillot O
    Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
    Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
    Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.